Mabura 40 Pen

Mabura 40 mg/0.8 mL Pen contains Adalimumab, a powerful monoclonal anti-tumor necrosis factor alpha (TNF-alpha) antibody used to manage a wide range of inflammatory diseases. It effectively treats conditions such as rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and psoriasis, providing relief from pain, swelling, and joint stiffness while improving physical function.

By targeting TNF-alpha, a key protein involved in inflammation, Mabura 40 mg/0.8 mL Pen helps reduce immune system overactivity, preventing further joint or tissue damage. This medication is administered via subcutaneous injection and should only be used under medical supervision. Before use, inform your doctor about any heart, kidney, or liver conditions, as well as any other medications you are taking.